Literature DB >> 27602892

A model of recurrent concussion that leads to long-term motor deficits, CTE-like tauopathy and exacerbation of an ALS phenotype.

Gretchen M Thomsen1, Annie M Ma, Ara Ko, Megan Y Harada, Livia Wyss, Patricia S Haro, Jean-Philippe Vit, Oksana Shelest, Peter Rhee, Clive N Svendsen, Eric J Ley.   

Abstract

BACKGROUND: Concussion injury is the most common form of traumatic brain injury (TBI). How recurrent concussions alter long-term outcomes is poorly understood, especially as related to the development of neurodegenerative disease. We evaluated the functional and pathological consequences of repeated TBI over time in wild type (WT) rats as well as rats harboring the human SOD1 mutation ("SOD1"), a model of familial amyotrophic lateral sclerosis (ALS).
METHODS: A total of 42 rats, 26 WT and 16 SOD1, were examined over a study period of 25 weeks (or endpoint). At postnatal day 60, 20 WT and 7 SOD1 rats were exposed to mild, bilateral TBI once per week for either 2 weeks (2×TBI) or 5 weeks (5×TBI) using a controlled cortical impact device. Six WT and nine SOD1 rats underwent sham injury with anesthesia alone. Twenty WT rats were euthanized at 12 weeks after first injury and six WT rats were euthanized at 25 weeks after first injury. SOD1 rats were euthanized when they reached ALS disease endpoint. Weekly body weights and behavioral assessments were performed. Tauopathy in brain tissue was analyzed using immunohistochemistry.
RESULTS: 2XTBI injured rats initially demonstrated recovery of motor function but failed to recover to baseline within the 12-week study period. Relative to both 2XTBI and sham controls, 5XTBI rats demonstrated significant deficits that persisted over the 12-week period. SOD1 5XTBI rats reached a peak body weight earlier than sham SOD1 rats, indicating earlier onset of the ALS phenotype. Histologic examination of brain tissue revealed that, in contrast with sham controls, SOD1 and WT TBI rats demonstrated cortical and corpus collosum thinning and tauopathy, which increased over time.
CONCLUSIONS: Unlike previous models of repeat brain injury, which demonstrate only transient deficits in motor function, our concussion model of repeat, mild, bilateral TBI induced long-lasting deficits in motor function, decreased cortical thickness, shrinkage of the corpus callosum, increased brain tauopathy, and earlier onset of ALS symptoms in SOD1 rats. This model may allow for a greater understanding of the complex relationship between TBI and neurodegenerative diseases and provides a potential method for testing novel therapeutic strategies.

Entities:  

Mesh:

Year:  2016        PMID: 27602892     DOI: 10.1097/TA.0000000000001248

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  11 in total

Review 1.  Impact of traumatic brain injury on amyotrophic lateral sclerosis: from bedside to bench.

Authors:  Colin K Franz; Divya Joshi; Elizabeth L Daley; Rogan A Grant; Kyriakos Dalamagkas; Audrey Leung; John D Finan; Evangelos Kiskinis
Journal:  J Neurophysiol       Date:  2019-05-22       Impact factor: 2.714

2.  The effects of mild closed head injuries on tauopathy and cognitive deficits in rodents: Primary results in wild type and rTg4510 mice, and a systematic review.

Authors:  Adam D Bachstetter; Josh M Morganti; Colleen N Bodnar; Scott J Webster; Emma K Higgins; Kelly N Roberts; Henry Snider; Shelby E Meier; Grant K Nation; Danielle S Goulding; Matthew Hamm; David K Powell; Moriel Vandsburger; Linda J Van Eldik; Jose F Abisambra
Journal:  Exp Neurol       Date:  2020-01-11       Impact factor: 5.330

Review 3.  Biomechanical simulation of traumatic brain injury in the rat.

Authors:  John D Finan
Journal:  Clin Biomech (Bristol, Avon)       Date:  2018-01-31       Impact factor: 2.063

Review 4.  A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies.

Authors:  Miranda E Orr; A Campbell Sullivan; Bess Frost
Journal:  Trends Pharmacol Sci       Date:  2017-04-25       Impact factor: 14.819

5.  Evidence of traumatic brain injury in headbutting bovids.

Authors:  Nicole L Ackermans; Merina Varghese; Terrie M Williams; Nicholas Grimaldi; Enna Selmanovic; Akbar Alipour; Priti Balchandani; Joy S Reidenberg; Patrick R Hof
Journal:  Acta Neuropathol       Date:  2022-05-17       Impact factor: 15.887

6.  Rapid Repeat Exposure to Subthreshold Trauma Causes Synergistic Axonal Damage and Functional Deficits in the Visual Pathway in a Mouse Model.

Authors:  Victoria Vest; Alexandra Bernardo-Colón; Dexter Watkins; Bohan Kim; Tonia S Rex
Journal:  J Neurotrauma       Date:  2019-01-08       Impact factor: 5.269

7.  Pathologic Thr175 tau phosphorylation in CTE and CTE with ALS.

Authors:  Alexander J Moszczynski; Wendy Strong; Kathy Xu; Ann McKee; Arthur Brown; Michael J Strong
Journal:  Neurology       Date:  2018-01-03       Impact factor: 9.910

8.  Apathy Is Correlated with Widespread Diffusion Tensor Imaging (DTI) Impairment in Amyotrophic Lateral Sclerosis.

Authors:  Cinzia Femiano; Francesca Trojsi; Giuseppina Caiazzo; Mattia Siciliano; Carla Passaniti; Antonio Russo; Alvino Bisecco; Mario Cirillo; Maria Rosaria Monsurrò; Fabrizio Esposito; Gioacchino Tedeschi; Gabriella Santangelo
Journal:  Behav Neurol       Date:  2018-10-22       Impact factor: 3.342

9.  Contact Sports as a Risk Factor for Amyotrophic Lateral Sclerosis: A Systematic Review.

Authors:  Ronen Blecher; Michael A Elliott; Emre Yilmaz; Joseph R Dettori; Rod J Oskouian; Akil Patel; Andrew Clarke; Mike Hutton; Robert McGuire; Robert Dunn; John DeVine; Bruce Twaddle; Jens R Chapman
Journal:  Global Spine J       Date:  2019-01-31

10.  Risk factors for amyotrophic lateral sclerosis: A regional United States case-control study.

Authors:  Angeline S Andrew; Walter G Bradley; Daniel Peipert; Tanya Butt; Kwadwo Amoako; Erik P Pioro; Rup Tandan; John Novak; Adam Quick; K Doug Pugar; Komal Sawlani; Bashar Katirji; Todd A Hayes; Pamela Cazzolli; Jiang Gui; Paul Mehta; D Kevin Horton; Elijah W Stommel
Journal:  Muscle Nerve       Date:  2020-10-18       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.